Michael Li, MD, MPH

For anyone attending #NCCN2025 in Orlando, I'm excited to be speaking during the immune checkpoint inhibitor toxicities session tomorrow (Friday 3/28). Looking forward to talking about immune-mediated hepatitis with an oncology audience! @NCCN @UCSFCancer #livertwitter

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️ ✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data Full text👉bit.ly/3VKZmcy #CPGs #LiverTwitter @EASLnews @EASLedu @AleksanderKrag

Apply for the #ACGInstitute Clinical Research Leadership Program! Learn research leadership skills to maintain a successful independent research program. For US physician members 2-15 years post-fellowship. Apply by November 15 ➡️ gi.org/crlp #CRLP @NeenaSAbrahamMD

Immunotherapy for hepatocellular carcinoma ➡️The next evolution in expanding access to liver transplantation Full text here👉journal-of-hepatology.eu/article/S0168-… @MichaelLiMD @SherrieBhoori #LiverTwitter

@MichaelLiMD et al found that outcomes of high-grade immune checkpoint inhibitor hepatitis were similar in hospitalized and non-hospitalized patients, suggesting that not all patients with high ALT levels need to be hospitalized ow.ly/3qLG50SyXlI

Check out our review of immunotherapy in HCC with a focus on its role in expanding access to curative liver transplantation, now out in @JHepatology. It was amazing working with Vincenzo Mazzaferro and Neil Mehta in this joint San Francisco-Milan effort! journal-of-hepatology.eu/article/S0168-…

Patients want to be in clinical trials but are rarely asked And - key point - if your trial seeks to help them FEEL better, they really want to be asked This study in @HepCommJournal from @MichaelLiMD is about PSC but the message is universal journals.lww.com/hepcomm/fullte…

Congrats @MelindaBWangMD! So happy that you’re staying, looking forward to working with you as a fellow!

Incredibly honoured to attend #TLM23 as an Emerging Liver Scholar! Thank you so much @ggarciatsao and @AASLDFoundation for the opportunity and for those who welcomed me to the community! 🌟struck and inspired to help improve liver related care! @AASLDtweets #LiverTwitter

Research by @MelindaBWangMD emphasizes the complexity of symptoms PSC patients experience & highlights the importance of considering these symptoms in clinical trials and future research. Learn more about why this research received a 2023 Abstract Award at aasldfoundation.org

🆕Now on Preprint: medrxiv.org/content/10.110… Our study comparing the @UCSF secure implementation of @OpenAI gpt-35-turbo #LLM model versus manual chart review for extraction of distinct data elements from #HCC imaging reports

Key points: ⭐️ Early GI/hepatology consultation was associated with faster liver enzyme normalization in patients with steroid-refractory ICI hepatitis ⭐️ A mediation analysis showed that this beneficial effect was driven by earlier initiation of additional immunosuppression

Hey #livertwitter, if you'd like some validation for our amazing specialty, check out our study in @JNCCN showing the benefits of early GI/liver consultation in immune checkpoint inhibitor hepatitis: jnccn.org/view/journals/… @AlexSVogel @JordanSackMD @UCSFTransplant @BrighamGI

Super excited to share our work developing the TeLeFI (Tele-Liver Frailty Index) to measure frailty in patients with cirrhosis via telemedicine! authors.elsevier.com/c/1h0tA5hx-WTX…

From the newest members of our amazing group to the leaders at the top, my work family inspires greatness. ⁦@JessBRubin⁩ ⁦@JoeCullaro⁩ ⁦@egnij⁩ ⁦@MonikaSarkarMD⁩ ⁦@MichaelLiMD⁩ ⁦@UCSFLiverCenter⁩ ⁦@UCSFTransplant⁩

This #WomensHistoryMonth, we're honored to highlight @MonikaSarkarMD, NIH-funded researcher in women's reproductive health and NAFLD and Chair, AASLD Women's Initiatives Committee. #LiverTwitter #WHM @norahterrault

@ebtapper @doctornikkid Jen Lai loves recommending Greek yogurt with nuts as a late night snack since you get protein without a lot of sodium and patients can order it from the hospital menu. I heard that suggestion so many times on rounds that I’m slightly worried she’s in the pocket of Big Yogurt.

@doctornikkid I make deals based on prefs. I run through a list until we have options for rotation: PB or meat or chese and crackers/sandwich, boost/ensure, zone bar, choc milk, nuts, etc but if very sick I start talking about ice cream/shakes etc

The perils of NPO When a patient with #cirrhosis sleeps, their liver makes less sugar/ketones. It is even worse after 3 days. How does the body solve the energy deficit? Muscle breakdown 1⃣Feed them protein 2⃣Late night snack 3⃣🚫NPO at midnight #livertwitter

Huge congrats to UCSF IM resident and (hopefully) future hepatologist @MelindaBWangMD for receiving an @AmCollegeGastro Medical Resident Research Award to study the effects of Stelara in PSC. So excited to work with you on this study and many more! #livertwitter @UCSFIMChiefs

@matownsend @BrighamGI Thanks Matt! Hope we can catch up at a GI meeting soon.

I'm so honored to receive an @AmCollegeGastro Junior Faculty Development Award to study outcomes of HCC immunotherapy! Many thanks to my amazing co-mentors Jen Lai and Larry Fong and my @UCSFTransplant and @UCSFCancer collaborators for their support. #ACGInstitute #livertwitter